Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-26 @ 6:51 AM
Study NCT ID:
NCT01211457
Status:
UNKNOWN
Last Update Posted:
2019-07-16
First Post:
2010-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
Sponsor:
Cyclacel Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2010-09-27
First Submit QC Date:
None
Study First Post Date:
2010-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-12
Last Update Post Date:
2019-07-16
Last Update Post Date Type:
ACTUAL